Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20. Epub 2006 Apr 10.

2.

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.

Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61. doi: 10.1073/pnas.0809154105. Epub 2008 Oct 31.

3.

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.

Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R.

Cancer Res. 2004 Nov 1;64(21):7668-72.

4.

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC.

Biomaterials. 2007 Feb;28(5):869-76. Epub 2006 Oct 20.

5.

Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.

Chen Z, Tai Z, Gu F, Hu C, Zhu Q, Gao S.

Eur J Pharm Biopharm. 2016 Oct;107:130-41. doi: 10.1016/j.ejpb.2016.07.007. Epub 2016 Jul 5.

PMID:
27393562
6.

In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.

Alibolandi M, Ramezani M, Abnous K, Sadeghi F, Atyabi F, Asouri M, Ahmadi AA, Hadizadeh F.

J Control Release. 2015 Jul 10;209:88-100. doi: 10.1016/j.jconrel.2015.04.026. Epub 2015 Apr 23.

PMID:
25912964
7.

Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery.

Gu F, Langer R, Farokhzad OC.

Methods Mol Biol. 2009;544:589-98. doi: 10.1007/978-1-59745-483-4_37.

8.

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.

Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim KS, Kim DE.

J Control Release. 2014 Dec 28;196:234-42. doi: 10.1016/j.jconrel.2014.10.018. Epub 2014 Oct 24.

PMID:
25450401
9.

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.

Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J, Liu K, Duan W.

Int J Nanomedicine. 2014 Feb 21;9:1083-96. doi: 10.2147/IJN.S59779. eCollection 2014.

10.

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.

Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1850-5. doi: 10.1073/pnas.1011379108. Epub 2011 Jan 13.

11.

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17939-44. doi: 10.1073/pnas.1011368107. Epub 2010 Oct 4.

12.

Polymeric nanoparticles for drug delivery.

Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC.

Methods Mol Biol. 2010;624:163-75. doi: 10.1007/978-1-60761-609-2_11.

PMID:
20217595
13.

Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.

Werner ME, Copp JA, Karve S, Cummings ND, Sukumar R, Li C, Napier ME, Chen RC, Cox AD, Wang AZ.

ACS Nano. 2011 Nov 22;5(11):8990-8. doi: 10.1021/nn203165z. Epub 2011 Oct 28.

14.

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.

Wu X, Ding B, Gao J, Wang H, Fan W, Wang X, Zhang W, Wang X, Ye L, Zhang M, Ding X, Liu J, Zhu Q, Gao S.

Int J Nanomedicine. 2011;6:1747-56. doi: 10.2147/IJN.S23747. Epub 2011 Aug 19.

15.

Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.

Pan M, Li W, Yang J, Li Z, Zhao J, Xiao Y, Xing Y, Zhang X, Ju W.

Medicine (Baltimore). 2017 Jul;96(30):e7405. doi: 10.1097/MD.0000000000007405.

16.

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, Farokhzad OC.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91. doi: 10.1073/pnas.0711714105. Epub 2008 Feb 13.

17.

Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.

Zhou W, Zhou Y, Wu J, Liu Z, Zhao H, Liu J, Ding J.

J Drug Target. 2014 Jan;22(1):57-66. doi: 10.3109/1061186X.2013.839683. Epub 2013 Oct 24.

PMID:
24156476
18.

Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.

Xu G, Yu X, Zhang J, Sheng Y, Liu G, Tao W, Mei L.

Int J Nanomedicine. 2016 Jun 22;11:2953-65. doi: 10.2147/IJN.S103513. eCollection 2016.

19.

PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.

Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.

Colloids Surf B Biointerfaces. 2016 Aug 1;144:8-20. doi: 10.1016/j.colsurfb.2016.03.071. Epub 2016 Mar 26.

20.

Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.

Jiao J, Zou Q, Zou MH, Guo RM, Zhu S, Zhang Y.

Neoplasma. 2016;63(4):569-75. doi: 10.4149/neo_2016_410.

PMID:
27268920

Supplemental Content

Support Center